Clinical Insights Into the Pathogenesis of Primary Pulmonary Hypertension
- 1 September 1998
- Vol. 114 (3) , 237S-241S
- https://doi.org/10.1378/chest.114.3_supplement.237s
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.American Journal of Respiratory and Critical Care Medicine, 1995
- Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.Circulation, 1989
- Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.Circulation, 1989
- Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated ratsMicrovascular Research, 1989
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Pharmacologically induced Pulmonary Vasodilatation in Children and Young Adults with Primary Pulmonary HypertensionChest, 1986
- Clinical primary pulmonary hypertension: three pathologic types.Circulation, 1977
- Primary Pulmonary HypertensionCirculation, 1970
- Vasoconstriction and Medial Hypertrophy in Pulmonary HypertensionCirculation, 1960
- PULMONARY HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOCONSTRICTIVE FACTORHeart, 1958